OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Showing 26-50 of 41 citing articles:
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
Sergio P. Alpuche-Lazcano, Matthew Stuible, Bassel Akache, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Sergio P. Alpuche-Lazcano, Matthew Stuible, Bassel Akache, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 6
A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
Feixia Gao, Mei Zheng, Jiangfeng Fan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Feixia Gao, Mei Zheng, Jiangfeng Fan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
Keda Chen, Ling Zhang, Zhongbiao Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Keda Chen, Ling Zhang, Zhongbiao Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants
Delphine Planas, Lin Peng, Lingyi Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27033-e27033
Open Access | Times Cited: 1
Delphine Planas, Lin Peng, Lingyi Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27033-e27033
Open Access | Times Cited: 1
Liposomes as vaccine delivery systems
Ning Wang, Xiaoyan Liu, Xuejiao Ma, et al.
Elsevier eBooks (2024), pp. 275-302
Closed Access | Times Cited: 1
Ning Wang, Xiaoyan Liu, Xuejiao Ma, et al.
Elsevier eBooks (2024), pp. 275-302
Closed Access | Times Cited: 1
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Second Boost of Omicron SARS-CoV-2 S1 Subunit Vaccine Induced Broad Humoral Immune Responses in Elderly Mice
Eun Kim, Muhammad S. Khan, Alessandro Ferrari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Eun Kim, Muhammad S. Khan, Alessandro Ferrari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Vaccination and Therapeutics
Walid Shaban Abdella, Ahmed Nabil Selim, Sheeren Diab, et al.
Advances in experimental medicine and biology (2024), pp. 165-184
Closed Access
Walid Shaban Abdella, Ahmed Nabil Selim, Sheeren Diab, et al.
Advances in experimental medicine and biology (2024), pp. 165-184
Closed Access
Recommend existing COVID-19 vaccines to reduce serious illness but new vaccines are needed to prevent transmission
Simon Fung
Drugs & Therapy Perspectives (2024)
Closed Access
Simon Fung
Drugs & Therapy Perspectives (2024)
Closed Access
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M TM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
Vivek Shinde, Anthonet Koen, Zaheer Hoosain, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Vivek Shinde, Anthonet Koen, Zaheer Hoosain, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
COVID-19 and Diarylamidines: The Parasitic Connection
John Hulme
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6583-6583
Open Access | Times Cited: 1
John Hulme
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6583-6583
Open Access | Times Cited: 1
NVX-CoV2373 ancestral and NVX-CoV2540 BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Traci L. Bricker, Astha Joshi, Nadia Soudani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Traci L. Bricker, Astha Joshi, Nadia Soudani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Neutrophil Elastase as a Predictor of Delivery in Pregnant Women with Preterm Labour
Kritika Srinivasan Rajsri, Meena Singh, Mana Rao
Exploratory Research and Hypothesis in Medicine (2023) Vol. 9, Iss. 2, pp. 128-137
Open Access | Times Cited: 1
Kritika Srinivasan Rajsri, Meena Singh, Mana Rao
Exploratory Research and Hypothesis in Medicine (2023) Vol. 9, Iss. 2, pp. 128-137
Open Access | Times Cited: 1
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies
Chris Wynne, Abundio Balgos, Jingxin Li, et al.
Infectious Diseases and Therapy (2023) Vol. 13, Iss. 1, pp. 57-78
Open Access | Times Cited: 1
Chris Wynne, Abundio Balgos, Jingxin Li, et al.
Infectious Diseases and Therapy (2023) Vol. 13, Iss. 1, pp. 57-78
Open Access | Times Cited: 1
Comparative Effectiveness of BNT162b2 and NVX-CoV2373 Vaccines in Korean Adults
Seon Kyeong Park, Young June Choe, SeungâAh Choe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Seon Kyeong Park, Young June Choe, SeungâAh Choe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Beta-Variant Recombinant Booster Vaccine Elicits Broad Cross-Reactive Neutralization of SARS-CoV-2 Including Omicron Variants
Delphine Planas, Lin Peng, Lingyi Zheng, et al.
(2023)
Closed Access
Delphine Planas, Lin Peng, Lingyi Zheng, et al.
(2023)
Closed Access
